A Phase II, Dose Ranging, Exploratory Clinical Study to Assess the Efficacy, Pharmacodynamics, Pharmacokinetics, and Safety of LNP1955 in Patients with Moderate to Severe Rheumatoid Arthritis.
Phase of Trial: Phase II
Latest Information Update: 09 Nov 2017
At a glance
- Drugs LNP 1955 (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Lupin
- 09 Nov 2017 This trial has been discontinued in Bulgaria.
- 27 Oct 2017 This trial has been completed in Hungary (end date: 11 Oct 2017).
- 23 Aug 2016 New trial record